320 related articles for article (PubMed ID: 24066341)
1. rhBMP-2/ACS grafts versus autogenous cancellous marrow grafts in large vertical defects of the maxilla: an unsponsored randomized open-label clinical trial.
Marx RE; Armentano L; Olavarria A; Samaniego J
Int J Oral Maxillofac Implants; 2013; 28(5):e243-51. PubMed ID: 24066341
[TBL] [Abstract][Full Text] [Related]
2. Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial.
de Freitas RM; Susin C; Spin-Neto R; Marcantonio C; Wikesjö UM; Pereira LA; Marcantonio E
J Clin Periodontol; 2013 Oct; 40(10):968-75. PubMed ID: 23998375
[TBL] [Abstract][Full Text] [Related]
3. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation.
Triplett RG; Nevins M; Marx RE; Spagnoli DB; Oates TW; Moy PK; Boyne PJ
J Oral Maxillofac Surg; 2009 Sep; 67(9):1947-60. PubMed ID: 19686934
[TBL] [Abstract][Full Text] [Related]
4. Ridge augmentation using recombinant bone morphogenetic protein-2 techniques: an experimental study in the canine.
Thoma DS; Jones A; Yamashita M; Edmunds R; Nevins M; Cochran DL
J Periodontol; 2010 Dec; 81(12):1829-38. PubMed ID: 20681814
[TBL] [Abstract][Full Text] [Related]
5. Vertical bone augmentation using recombinant bone morphogenetic protein, mineralized bone allograft, and titanium mesh: a retrospective cone beam computed tomography study.
Misch CM; Jensen OT; Pikos MA; Malmquist JP
Int J Oral Maxillofac Implants; 2015; 30(1):202-7. PubMed ID: 25615925
[TBL] [Abstract][Full Text] [Related]
6. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
Boyne PJ
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
[TBL] [Abstract][Full Text] [Related]
7. Sinus augmentation using rhBMP-2/ACS in a mini-pig model: relative efficacy of autogenous fresh particulate iliac bone grafts.
Lee J; Susin C; Rodriguez NA; de Stefano J; Prasad HS; Buxton AN; Wikesjö UM
Clin Oral Implants Res; 2013 May; 24(5):497-504. PubMed ID: 22276816
[TBL] [Abstract][Full Text] [Related]
8. Histological analysis and gene expression profile following augmentation of the anterior maxilla using rhBMP-2/ACS versus autogenous bone graft.
de Freitas RM; Susin C; Tamashiro WM; Chaves de Souza JA; Marcantonio C; Wikesjö UM; Pereira LA; Marcantonio E
J Clin Periodontol; 2016 Dec; 43(12):1200-1207. PubMed ID: 27440671
[TBL] [Abstract][Full Text] [Related]
9. Reconstruction of alveolar defects using titanium-reinforced porous polyethylene as a containment device for recombinant human bone morphogenetic protein 2.
Hart KL; Bowles D
J Oral Maxillofac Surg; 2012 Apr; 70(4):811-20. PubMed ID: 22209107
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial.
Jones AL; Bucholz RW; Bosse MJ; Mirza SK; Lyon TR; Webb LX; Pollak AN; Golden JD; Valentin-Opran A;
J Bone Joint Surg Am; 2006 Jul; 88(7):1431-41. PubMed ID: 16818967
[TBL] [Abstract][Full Text] [Related]
11. Vertical Bone Augmentation Using Deproteinized Bovine Bone Mineral, Absorbable Collagen Sponge, and Recombinant Human Bone Morphogenetic Protein-2: An In Vivo Study in Rabbits.
Kim YJ; de Molon RS; Horiguti FR; Contador GP; Coelho MA; Mascarenhas VI; de Souza Faloni AP; Cirelli JA; Sendyk WR
Int J Oral Maxillofac Implants; 2018; 33(3):512–522. PubMed ID: 29543927
[TBL] [Abstract][Full Text] [Related]
12. Effects of Recombinant Human Bone Morphogenetic Protein-2 on Vertical Bone Augmentation in a Canine Model.
Hsu YT; Al-Hezaimi K; Galindo-Moreno P; O'Valle F; Al-Rasheed A; Wang HL
J Periodontol; 2017 Sep; 88(9):896-905. PubMed ID: 28548887
[TBL] [Abstract][Full Text] [Related]
13. Heterotopic ossification following single-level anterior cervical discectomy and fusion: results from the prospective, multicenter, historically controlled trial comparing allograft to an optimized dose of rhBMP-2.
Arnold PM; Anderson KK; Selim A; Dryer RF; Kenneth Burkus J
J Neurosurg Spine; 2016 Sep; 25(3):292-302. PubMed ID: 27129045
[TBL] [Abstract][Full Text] [Related]
14. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
Haid RW; Branch CL; Alexander JT; Burkus JK
Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
[TBL] [Abstract][Full Text] [Related]
15. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
[TBL] [Abstract][Full Text] [Related]
16. Translational research: The CD34+ cell is crucial for large-volume bone regeneration from the milieu of bone marrow progenitor cells in craniomandibular reconstruction.
Marx RE; Harrell DB
Int J Oral Maxillofac Implants; 2014; 29(2):e201-9. PubMed ID: 24683583
[TBL] [Abstract][Full Text] [Related]
17. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
[TBL] [Abstract][Full Text] [Related]
18. Comparing the Effect of Nonactivated Platelet-Rich Plasma, Activated Platelet-Rich Plasma, and Bone Morphogenetic Protein-2 on Calvarial Bone Regeneration.
Jeon YR; Jung BK; Roh TS; Kang EH; Lee WJ; Rah DK; Lew DH; Yun IS
J Craniofac Surg; 2016 Mar; 27(2):317-21. PubMed ID: 26967070
[TBL] [Abstract][Full Text] [Related]
19. Use of titanium mesh for staged localized alveolar ridge augmentation: clinical and histologic-histomorphometric evaluation.
Proussaefs P; Lozada J
J Oral Implantol; 2006; 32(5):237-47. PubMed ID: 17069168
[TBL] [Abstract][Full Text] [Related]
20. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates.
Hanisch O; Tatakis DN; Rohrer MD; Wöhrle PS; Wozney JM; Wikesjö UM
Int J Oral Maxillofac Implants; 1997; 12(6):785-92. PubMed ID: 9425759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
